2021
DOI: 10.1021/acs.jced.0c00912
|View full text |Cite
|
Sign up to set email alerts
|

PC-SAFT Modeling of Phase Equilibria Relevant for Lipid-Based Drug Delivery Systems

Abstract: In this work we investigated the solubilities of 10 active pharmaceutical ingredients (APIs), namely, fenofibrate, ibuprofen, cinnarizine, carbamazepine, indomethacin, naproxen, griseofulvin, glibenclamide, felodipine, and praziquantel in the pharmaceutically relevant excipients tricaprylin, Lauroglycol FCC, Capryol 90, Kolliphor TPGS, ethanol, and monolaurin. API solubilities were either determined gravimetrically, with high-performance liquid chromatography, or with differential scanning calorimetry. Mutual … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 36 publications
0
7
0
Order By: Relevance
“…The solid–liquid equilibrium phase diagrams are shown in Figure . A previous publication reported that the solubility data of felodipine in ethanol at 298.15 K in mass fraction was 0.16351 . In this work, the mass fraction solubility data of felodipine in ethanol at 298.15 K is 0.10113.…”
Section: Resultsmentioning
confidence: 52%
See 1 more Smart Citation
“…The solid–liquid equilibrium phase diagrams are shown in Figure . A previous publication reported that the solubility data of felodipine in ethanol at 298.15 K in mass fraction was 0.16351 . In this work, the mass fraction solubility data of felodipine in ethanol at 298.15 K is 0.10113.…”
Section: Resultsmentioning
confidence: 52%
“…A previous publication reported that the solubility data of felodipine in ethanol at 298.15 K in mass fraction was 0.16351. 23 In this work, the mass fraction solubility data of felodipine in ethanol at 298.15 K is 0.10113. This error is acceptable, which may be owing to different experimental methods, temperature control accuracy, and test conditions.…”
Section: Resultsmentioning
confidence: 93%
“…The solubility of the drug in polymers PEG 6000 or PVP K30 (the mass ratios of the drug in the polymers are 40, 60, and 80%) was determined by DSC. , The DSC was calibrated in weight (standard calibration weight), temperature and enthalpy of fusion (zinc), and heat capacity (sapphire). The drug and polymer physical mixtures were mixed by a mortar and pestle for 30 min.…”
Section: Methodsmentioning
confidence: 99%
“…The drug is usually considered a solute and the polymer is considered a solvent. The melting temperature of the drug is usually considered as the dissolving temperature of the drug in the polymer. , Thus, the solubility of the drug in the polymer (the heating rate is 0 K/min) was obtained by extrapolation from experiment data.…”
Section: Methodsmentioning
confidence: 99%
“…Over the last decade, interest regarding the use of ML algorithms across diverse disciplines in pharmaceutical design and development has grown [ 11 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ]. While ML models have been produced to optimise lipid-based formulation (LBF) development [ 3 , 22 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ], the application of more novel ML approaches for bio-enabling formulations currently focuses on solid dispersions (SDs) [ 21 , 34 , 35 ]. However, their application to LBFs, particularly supersaturated LBFs (sLBFs), remains unexplored.…”
Section: Introductionmentioning
confidence: 99%